Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/36067
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wareham N.J. | en |
dc.contributor.author | Long G.H. | en |
dc.contributor.author | Hare M.J.L. | en |
dc.contributor.author | Irving G. | en |
dc.contributor.author | Boothby C.E. | en |
dc.contributor.author | Griffin S.J. | en |
dc.contributor.author | Strelitz J. | en |
dc.contributor.author | Ahern A.L. | en |
dc.date.accessioned | 2021-05-14T12:13:14Z | en |
dc.date.available | 2021-05-14T12:13:14Z | en |
dc.date.copyright | 2019 | en |
dc.date.created | 20190724 | en |
dc.date.issued | 2019-07-24 | en |
dc.identifier.citation | Diabetologia. 62 (8) (pp 1391-1402), 2019. Date of Publication: 01 Aug 2019. | en |
dc.identifier.issn | 0012-186X | en |
dc.identifier.uri | https://repository.monashhealth.org/monashhealthjspui/handle/1/36067 | en |
dc.description.abstract | Aims/hypothesis: Adults with type 2 diabetes are at high risk of developing cardiovascular disease (CVD). Evidence of the impact of weight loss on incidence of CVD events among adults with diabetes is sparse and conflicting. We assessed weight change in the year following diabetes diagnosis and estimated associations with 10 year incidence of CVD events and all-cause mortality. Method(s): In a cohort analysis among 725 adults with screen-detected diabetes enrolled in the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION)-Cambridge trial, we estimated HRs for weight change in the year following diabetes diagnosis and 10 year incidence of CVD (n = 99) and all-cause mortality (n = 95) using Cox proportional hazards regression. We used linear regression to estimate associations between weight loss and CVD risk factors. Models were adjusted for age, sex, baseline BMI, smoking, occupational socioeconomic status, cardio-protective medication use and treatment group. Result(s): Loss of >=5% body weight in the year following diabetes diagnosis was associated with improvements in HbA1c and blood lipids and a lower hazard of CVD at 10 years compared with maintaining weight (HR 0.52 [95% CI 0.32, 0.86]). The associations between weight gain vs weight maintenance and CVD (HR 0.41 [95% CI 0.15, 1.11]) and mortality (HR 1.63 [95% CI 0.83, 3.19]) were less clear. Conclusions/interpretation: Among adults with screen-detected diabetes, loss of >=5% body weight during the year after diagnosis was associated with a lower hazard of CVD events compared with maintaining weight. These results support the hypothesis that moderate weight loss may yield substantial long-term CVD reduction, and may be an achievable target outside of specialist-led behavioural treatment programmes.Copyright © 2019, The Author(s). | en |
dc.language | en | en |
dc.language | English | en |
dc.publisher | Springer Verlag (E-mail: service@springer.de) | en |
dc.relation.ispartof | Diabetologia | en |
dc.title | Moderate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality. | en |
dc.type | Article | en |
dc.type.studyortrial | Observational study (cohort, case-control, cross sectional or survey) | - |
dc.identifier.doi | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1007/s00125-019-4886-1 | en |
dc.publisher.place | Germany | en |
dc.identifier.pubmedid | 31062041 [http://www.ncbi.nlm.nih.gov/pubmed/?term=31062041] | en |
dc.identifier.source | 627599806 | en |
dc.identifier.institution | (Strelitz, Ahern, Boothby, Wareham, Griffin) MRC Epidemiology Unit, Institute of Metabolic Science, Cambridge Biomedical Campus, University of Cambridge School of Clinical Medicine, Box 285, Cambridge CB2 0QQ, United Kingdom (Long) AstraZeneca Pharmaceuticals, Cambridge, United Kingdom (Hare) Departments of Endocrinology, Diabetes and Vascular Medicine, Monash Health, Melbourne, VIC, Australia (Irving, Griffin) Primary Care Unit, Institute of Public Health, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom | en |
dc.description.address | J. Strelitz, MRC Epidemiology Unit, Institute of Metabolic Science, Cambridge Biomedical Campus, University of Cambridge School of Clinical Medicine, Box 285, Cambridge CB2 0QQ, United Kingdom. E-mail: jean.strelitz@mrc-epid.cam.ac.uk | en |
dc.description.publicationstatus | Embase | en |
dc.rights.statement | Copyright 2019 Elsevier B.V., All rights reserved. | en |
dc.subect.keywords | Cardiovascular disease Diabetes Epidemiology Weight loss | en |
dc.identifier.authoremail | Strelitz J.; jean.strelitz@mrc-epid.cam.ac.uk | en |
dc.description.grant | No: 08/116/300 Organization: (HTA) *Health Technology Assessment Programme* Organization No: 501100000664 Country: United Kingdom No: G061895 Organization: (WT) *Wellcome Trust* Organization No: 100010269 Country: United Kingdom No: MC_UU_12015/4 Organization: (MRC) *Medical Research Council* Organization No: 501100000265 Country: United Kingdom No: RP-PG-0606-1259 Organization: (PGfAR) *Programme Grants for Applied Research* Organization No: 501100007602 Country: United Kingdom | en |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.openairetype | Article | - |
Appears in Collections: | Articles |
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.